Why the study?
Does primary angioplasty improve outcomes compared to thrombolysis in patients with acute myocardial infarction?
Does primary angioplasty improve outcomes compared to thrombolysis in patients with acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Primary angioplasty, particularly with stent implantation, is the superior and preferred reperfusion strategy for acute myocardial infarction compared to thrombolysis.
Current evidence from several clinical trials indicates that primary angioplasty in patients with acute myocardial infarction (AMI) appears superior reperfusion therapy to immediate thrombolysis, even when transfer to an angioplasty center is necessary. Thus, organization of ambulance systems and adequate angioplasty facilities appears to be the key issue in providing the most effective contemporary reperfusion therapy for AMI. Furthermore, on-site primary coronary angioplasty in high-risk AMI patients at hospitals with no cardiac surgery on-site is nowdays considered safe, effective, and faster than angioplasty after transfer to a surgical facility. Randomized trials have demonstrated the superiority of primary angioplasty with stent implantation over balloon angioplasty alone in the treatment of AMI, including patients with diabetes. Stent use has been associated with significant decreases in length of stay, major adverse cardiovascular events, and in-hospital mortality. Finally, because of the risk of stent thrombosis, the issue of whether drug-eluting stents are safe or even more beneficial than bare-metal stents in patients with AMI, as in other non-AMI patient groups, remains uncertain, although preliminary data seem to favour the use of drug-eluting stents. I N T R O D U C T I O N Acute myocardial infarction (AMI) has been associated with thrombotic occlusion of a coronary artery as early as in 1793 when an autopsy was performed on Sir James Hunter, a famous surgeon who died suddenly following a violent argument with hospital administrators in London. The term “acute coronary thrombosis” was well established in medical literature and its connotation was reaffirmed following the seminal study of DeWood et al in 1980. Thrombolytic agents were discovered in the 1950s and, following long debates about their clinical benefits, they entered clinical routine in 1986. However, it is now evident that although fresh thrombus represents the major pathological finding in acutely occluded coronary arteries, it is found in less than 70% of the cases. This is in keeping with the current success rates of thrombolytic trials that, even with the use of aggressive protocols, result in restoration of normal coronary flow (TIMI 3) in only 60 to 70% of the cases. It seems that a considerable proportion of AMI might be due to spontaneous dissection and/or severe intramural EDITORIAl Department of Cardiology, Athens Euroclinic, Athens, Greece, & St Thomas’ Hospital, London, England HOSPITAL CHRONICLES 2007, 2(4): 143–150
No takes yet. Share an insight, caveat, or question.
Demosthenes G. Katritsis (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: